Table 3. The effect of the molecular and clinical variables on progression-free survival in resectable low-grade pancreatic cancer patients.
| Univariate | ||||
|---|---|---|---|---|
| 95% | CI | |||
| HR | Lower | Upper | P-value | |
| Age | 0.588 | |||
| > 65 years vs < 65 years | 1.313 | 0.490 | 3.518 | |
| Sex | 0.540 | |||
| Male vs Female | 1.336 | 0.528 | 3.381 | |
| Adjuvant treatment | 0.329 | |||
| No vs Yes | 1.718 | 0.579 | 5.093 | |
| Tumor size | 0.926 | |||
| >2 cm vs <2cm | 1.050 | 0.373 | 2.959 | |
| Stage | 0.173 | |||
| II vs I | 2.540 | 0.571 | 11.306 | |
| pT | 0.341 | |||
| T3 vs T1-T2 | 1.854 | 0.521 | 6.601 | |
| pN | 0.565 | |||
| N1 vs N0 | 1.385 | 0.461 | 4.159 | |
| Tumor location | 0.263 | |||
| Pancreas vs Others | 1.924 | 0.611 | 6.053 | |
| Vascular Invasion | 0.728 | |||
| Yes vs No | 1.220 | 0.399 | 3.731 | |
| Neural Invasion | 0.728 | |||
| Yes vs No | 1.220 | 0.399 | 3.731 | |
| Lymph nodes affected | 0.312 | |||
| Yes vs No | 1.719 | 0.602 | 4.911 | |
| UNR | 0.036 | |||
| Low vs High | 8.914 | 1.159 | 68.584 | |
HR: hazard ratio; CI: confidence interval; vs: versus